Bio-Rad Laboratories (NYSE:BIO.B – Get Free Report) will be posting its quarterly earnings results after the market closes on Thursday, August 1st.
Bio-Rad Laboratories (NYSE:BIO.B – Get Free Report) last released its quarterly earnings data on Tuesday, May 7th. The company reported $2.29 earnings per share for the quarter. Bio-Rad Laboratories had a positive return on equity of 3.59% and a negative net margin of 12.37%. The firm had revenue of $610.82 million during the quarter.
Bio-Rad Laboratories Price Performance
Shares of Bio-Rad Laboratories stock opened at $294.23 on Tuesday. The company has a current ratio of 6.57, a quick ratio of 4.89 and a debt-to-equity ratio of 0.13. The firm’s 50-day moving average is $284.71 and its two-hundred day moving average is $305.85. Bio-Rad Laboratories has a 1 year low of $271.00 and a 1 year high of $373.78.
Bio-Rad Laboratories Company Profile
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
Featured Stories
- Five stocks we like better than Bio-Rad Laboratories
- Do ETFs Pay Dividends? What You Need to Know
- Should You Invest in Bonds? Here’s What to Know
- Stock Market Sectors: What Are They and How Many Are There?
- Why This Manufacturer is Committing to a Massive Buyback Program
- 3 Stocks to Consider Buying in October
- Top 2 Cheap Healthcare Stocks to Buy as Sector Outperforms
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.